Elevated Inflammatory Markers in Dialysis Patients

Prevalence and Causes of Inflammation

The uremic milieu itself contributes to elevated inflammatory markers in dialysis patients 1, 2
Dialysis-related factors such as bioincompatible dialysis membranes, impure dialysate, and back-filtration contribute to elevated inflammatory markers in dialysis patients 3
Clotted access grafts and persistent infections contribute to elevated inflammatory markers in dialysis patients 1, 2
Failed kidney grafts in transplant patients returning to dialysis contribute to elevated inflammatory markers in dialysis patients 2
Vascular calcification and oxidative stress contribute to elevated inflammatory markers in dialysis patients 3

Elevated CRP predicts all-cause and cardiovascular mortality in both hemodialysis and peritoneal dialysis patients 1, 4
Inflammatory markers are associated with increased risk of cardiovascular events in dialysis patients 1

Regular assessment of CRP levels in dialysis patients is recommended to identify sources of inflammation 3
A highly sensitive method for measuring CRP is recommended for dialysis patients 3
When elevated inflammatory markers are detected, clinicians should look for occult infectious processes, such as clotted arteriovenous grafts 3
Clinicians should evaluate for graft intolerance syndrome in patients with failed kidney transplants 5, 6
Clinicians should monitor for symptoms of cardiovascular disease in dialysis patients 1, 4

There is no consensus on the optimal "cut-off" point of CRP to define inflammation in CKD patients 1, 3
Single determinations of inflammatory markers may be problematic since they vary with time in dialysis patients 1
Inflammatory markers should be interpreted in conjunction with clinical findings, as elevated levels can result from multiple causes in dialysis patients 3
In failed kidney transplant patients, elevated inflammatory markers may indicate graft intolerance syndrome rather than infection 5, 6

The primary approach to treating elevated CRP in ESRD patients involves systematically identifying and addressing specific sources of inflammation rather than targeting CRP itself, as no pharmacologic therapy has been proven to substantially reduce CRP levels in this population 7
Measure CRP using a highly sensitive method on a regular basis, and obtain multiple measurements over time, as inflammatory markers fluctuate significantly in dialysis patients and single determinations may be misleading 7
Switch to biocompatible dialysis membranes if not already in use, to address dialysis-related factors contributing to inflammation 7
Ensure ultrapure dialysate to eliminate endotoxin and bacterial contamination, as part of the initial assessment strategy 7
Address back-filtration issues, as they may contribute to inflammation in ESRD patients 7
Hypoalbuminemia in the presence of elevated CRP does not necessarily indicate protein-energy malnutrition, as inflammation independently suppresses albumin levels, according to the American Journal of Kidney Diseases 8

Elevated CRP predicts all-cause and cardiovascular mortality in both hemodialysis and peritoneal dialysis patients, highlighting the importance of regular CRP monitoring 7
There is no consensus on the optimal CRP cut-off point to define inflammation in CKD patients, emphasizing the need for individualized assessment and monitoring 7